A detailed history of Mariner, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Mariner, LLC holds 26,107 shares of LQDA stock, worth $287,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,107
Previous 30,516 14.45%
Holding current value
$287,438
Previous $450,000 30.44%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$11.96 - $15.71 $52,731 - $69,265
-4,409 Reduced 14.45%
26,107 $313,000
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $227,703 - $335,637
20,062 Added 191.91%
30,516 $450,000
Q4 2023

Feb 14, 2024

SELL
$5.77 - $12.19 $235,883 - $498,339
-40,881 Reduced 79.64%
10,454 $125,000
Q3 2023

Nov 13, 2023

BUY
$6.27 - $8.15 $227,883 - $296,211
36,345 Added 242.46%
51,335 $325,000
Q2 2023

Aug 11, 2023

SELL
$6.63 - $9.9 $6,033 - $9,009
-910 Reduced 5.72%
14,990 $117,000
Q1 2023

May 12, 2023

BUY
$5.72 - $7.91 $90,948 - $125,769
15,900 New
15,900 $110,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.